A process for preparing 4-pentafluorosulfanylbenzoylguanidines of formula I ##STR00001## wherein R1 to R4 have the meanings indicated in the specification. The compounds of formula I are NHE1 inhibitors and can be employed, for example, for the treatment of cardiovascular disorders.

 
Web www.patentalert.com

< Target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto

> Method of making dialkyl ketones

> (Meth) acryloyl group-containing oxetane compound and production method thereof

~ 00579